FibroGen
FGEN
#9943
Rank
HK$0.27 B
Marketcap
HK$68.33
Share price
0.92%
Change (1 day)
-33.61%
Change (1 year)

Market capitalization of FibroGen (FGEN)

Market cap: HK$0.27 Billion

As of January 2026 FibroGen has a market cap of HK$0.27 Billion. This makes FibroGen the world's 9943th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of FibroGen from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$0.28 B-38.26%
2024HK$0.45 B-33.34%
2023HK$0.68 B-94.21%
2022HK$11.76 B15.38%
2021HK$10.19 B-61.05%
2020HK$26.16 B-10.63%
2019HK$29.28 B-5.43%
2018HK$30.96 B1.71%
2017HK$30.44 B190.43%
2016HK$10.48 B-28.4%
2015HK$14.63 B16.91%
2014HK$12.52 B
2026HK$0.27 B-1.32%

End of Day market cap according to different sources

On Dec 31st, 2025 the market cap of FibroGen was reported to be:

HK$0.27 Billion
by Nasdaq info icon info icon
HK$0.27 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Illumina
ILMN
HK$156.89 B 56,656.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
HK$85.07 B 30,676.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Accelerate Diagnostics
AXDX
HK$6.69 M-97.58%๐Ÿ‡บ๐Ÿ‡ธ USA